Market Overview

UPDATE: Jefferies Downgrades Elan Corp on PRGO Takeout

Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

In a report published on Monday, Jefferies analyst Oren G. Livnat downgraded Elan Corp (NYSE: ELN) from Buy to Hold and lowered the price target on the company from $19 to $15.

In the report, Jefferies stated, "LN agreed to be acquired by Perrigo for ~$8.6B or $16.50/shr (based on prior PRGO stock price), a >40% premium to where ELN was following Bapi Ph.3 failure, and >25% above the last Royalty Pharma hostile bid. Given the open/ formal sales process, we do not see higher bids now and expect ELN shareholder approval and close by end'13."

Elan Corp closed on Friday at $14.93.

Latest Ratings for ELN

Jul 2013JefferiesDowngradesBuyHold
Jun 2013JefferiesMaintainsBuy
Feb 2013Leerink SwannUpgradesUnderperformMarket Perform

View More Analyst Ratings for ELN
View the Latest Analyst Ratings

Posted-In: Jefferies Oren G. LivnatAnalyst Color Downgrades Analyst Ratings


Related Articles (ELN)

View Comments and Join the Discussion!